Restructuring Actions (Tables)
|
12 Months Ended |
Dec. 31, 2020 |
|---|
| 2020 Restructuring Actions | Operational/Marketing Capability Restructuring |
|
| Restructuring Cost and Reserve |
|
| Schedule of restructuring charges by income statement line |
| | | | (Millions) | | Fourth Quarter 2020 | Cost of sales | | $ | 51 | Selling, general and administrative expenses | | | 79 | Research, development and related expenses | | | 7 | Total operating income impact | | $ | 137 |
|
| Components of restructuring by business segment |
| | | | | | | | | | | | Fourth Quarter 2020 | (Millions) | | Employee-Related | | Asset-Related and Other | | Total | Safety and Industrial | | $ | 36 | | $ | 7 | | $ | 43 | Transportation and Electronics | | | 16 | | | 12 | | | 28 | Health Care | | | 23 | | | 3 | | | 26 | Consumer | | | 10 | | | 1 | | | 11 | Corporate and Unallocated | | | 16 | | | 13 | | | 29 | Total Operating Expense | | $ | 101 | | $ | 36 | | $ | 137 |
|
| Accrued restructuring action balances |
| | | | | | | | | | (Millions) | | Employee-Related | | Asset-Related and Other | | Total | Expense incurred in the fourth quarter of 2020 | | $ | 101 | | $ | 36 | | $ | 137 | Non-cash changes | | | — | | | (36) | | | (36) | Accrued restructuring action balances as of December 31, 2020 | | $ | 101 | | $ | — | | $ | 101 |
|
| 2020 Restructuring Actions | Drug delivery business |
|
| Restructuring Cost and Reserve |
|
| Schedule of restructuring charges by income statement line |
| | | | | (Millions) | | Second Quarter 2020 | | Cost of sales | | $ | 42 | | Selling, general and administrative expenses | | | 12 | | Research, development and related expenses | | | 1 | | Total operating income impact | | $ | 55 | |
|
| Accrued restructuring action balances |
| | | | | | | | | | | (Millions) | | Employee-Related | | Asset-Related and Other | | Total | | Expense incurred in the second quarter of 2020 | | $ | 32 | | $ | 23 | | $ | 55 | | Non-cash changes | | | — | | | (14) | | | (14) | | Cash payments | | | (14) | | | — | | | (14) | | Adjustments | | | (3) | | | — | | | (3) | | Accrued divestiture-related restructuring action balances as of December 31, 2020 | | $ | 15 | | $ | 9 | | $ | 24 | |
|
| 2020 Restructuring Actions | Other Restructuring |
|
| Restructuring Cost and Reserve |
|
| Schedule of restructuring charges by income statement line |
| | | | | (Millions) | | Second Quarter 2020 | | Cost of sales | | $ | 13 | | Selling, general and administrative expenses | | | 37 | | Research, development and related expenses | | | 8 | | Total operating income impact | | $ | 58 | |
|
| Components of restructuring by business segment |
| | | | | | | | | | | | | Second Quarter 2020 | | (Millions) | | Employee-Related | | Asset-Related and Other | | Total | | Safety and Industrial | | $ | 7 | | $ | — | | $ | 7 | | Transportation and Electronics | | | 11 | | | — | | | 11 | | Health Care | | | 12 | | | — | | | 12 | | Consumer | | | 5 | | | — | | | 5 | | Corporate and Unallocated | | | — | | | 23 | | | 23 | | Total Operating Expense | | $ | 35 | | $ | 23 | | $ | 58 | |
|
| Accrued restructuring action balances |
| | | | | | | | | | | (Millions) | | Employee-Related | | Asset-Related | | Total | | Expense incurred in the second quarter of 2020 | | $ | 35 | | $ | 23 | | $ | 58 | | Non-cash changes | | | — | | | (23) | | | (23) | | Cash payments | | | (2) | | | — | | | (2) | | Adjustments | | | (9) | | | — | | | (9) | | Accrued restructuring action balances as of December 31, 2020 | | $ | 24 | | $ | — | | $ | 24 | |
|
| 2019 Restructuring Actions |
|
| Restructuring Cost and Reserve |
|
| Schedule of restructuring charges by income statement line |
| | | | | (Millions) | | Second and Fourth Quarter 2019 | | Cost of sales | | $ | 72 | | Selling, general and administrative expenses | | | 137 | | Research, development and related expenses | | | 37 | | Total operating income impact | | | 246 | | Other expense (income), net | | | 36 | | Total income before income taxes impact | | $ | 282 | |
|
| Components of restructuring by business segment |
| | | | | | | | | | | | | Second and Fourth Quarter 2019 | | (Millions) | | Employee-Related | | Asset-Related | | Total | | Safety and Industrial | | $ | 50 | | $ | — | | $ | 50 | | Transportation and Electronics | | | 31 | | | — | | | 31 | | Health Care | | | 17 | | | — | | | 17 | | Consumer | | | 8 | | | — | | | 8 | | Corporate and Unallocated | | | 100 | | | 40 | | | 140 | | Total Operating Expense | | $ | 206 | | $ | 40 | | $ | 246 | |
|
| Accrued restructuring action balances |
| | | | | | | | | | | (Millions) | | Employee-Related | | Asset-Related | | Total | | Expense incurred in the second quarter and fourth quarter of 2019 | | $ | 242 | | $ | 40 | | $ | 282 | | Non-cash changes | | | (36) | | | (40) | | | (76) | | Cash payments | | | (52) | | | — | | | (52) | | Adjustments | | | (14) | | | — | | | (14) | | Accrued restructuring action balances as of December 31, 2019 | | $ | 140 | | $ | — | | $ | 140 | | Cash Payments | | | (51) | | | — | | | (51) | | Adjustments | | | (59) | | | — | | | (59) | | Accrued restructuring action balances as of December 31, 2020 | | $ | 30 | | $ | — | | $ | 30 | |
|
| 2018 Restructuring Actions |
|
| Restructuring Cost and Reserve |
|
| Schedule of restructuring charges by income statement line |
| | | | | (Millions) | | Second and Fourth Quarter 2018 | | Cost of sales | | $ | 27 | | Selling, general and administrative expenses | | | 105 | | Research, development and related expenses | | | 5 | | Total | | $ | 137 | |
|
| Accrued restructuring action balances |
| | | | | | | | | | | (Millions) | | Employee-Related | | Asset-Related | | Total | | Expense incurred in the second quarter and fourth quarter of 2018 | | $ | 125 | | $ | 12 | | $ | 137 | | Non-cash changes | | | — | | | (12) | | | (12) | | Cash payments | | | (24) | | | — | | | (24) | | Adjustments | | | (17) | | | — | | | (17) | | Accrued restructuring action balances as of December 31, 2018 | | $ | 84 | | $ | — | | $ | 84 | | Cash payments | | | (76) | | | — | | | (76) | | Adjustments | | | (5) | | | — | | | (5) | | Accrued restructuring action balances as of December 31, 2019 | | $ | 3 | | $ | — | | $ | 3 | |
|